VR Logo

Anebulo Pharmaceuticals Inc. (ANEB) download report


Healthcare | Biotechnology & Pharma Research

Anebulo Pharmaceuticals Inc. (ANEB) Premium Coverage

53 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction.

IPO Date: 07-May-2021

Founder & Chairman: Dr. Joseph F. Lawler M.D., Ph.D.

Chief Financial Officer: Mr. Rex Merchant CFA

Listing: NASDAQ: ANEB

Country: United States

Headquarters: Lakeway, TX

Website: https://www.anebulo.com

Key Facts

Market cap: $110.65 Mln

Revenue (TTM): $0.00 Mln

Earnings (TTM): $-33.61 Mln

Cash: $16.55 Mln

Total Debt: $0.00 Mln

Insider's Holding: 75.55%

Liquidity: Low

52 Week range: $2.67 - 7.89

Shares outstanding: 23,344,600

Stock Performance

Time Period Anebulo Pharmaceuticals (ANEB) S&P BSE Sensex S&P Small-Cap 600
YTD-12.60-9.18-18.78
1 month82.82-4.78-8.00
3 months-24.08-9.66-13.65
1 Year-21.190.81-17.19
3 Years--10.336.10
5 Years--11.345.87
10 Years--11.749.84
As on 01-Jul-2022